United States

People: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

23 Jun 2017
Change (% chg)

$0.15 (+0.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kumar, Ravindra 

Dr. Ravindra Kumar, Ph.D., is Senior Vice President, Chief Scientific Officer of Acceleron Pharma, Inc. He joined Acceleron in March 2004 and is currently our Senior Vice President and Chief Scientific Officer. Dr. Kumar established and currently leads our discovery research. Previously, Dr. Kumar worked for 12 years at Genetics Institute and Wyeth Pharmaceuticals. At Genetics Institute, Dr. Kumar was a key member of the Small Molecule Drug Discovery group and was responsible for cell biology. Following the integration of discovery functions from Genetics Institute and Wyeth Pharmaceuticals, Dr. Kumar served as Senior Scientist in the Biological Chemistry group. Dr. Kumar is the author of several key scientific manuscripts in the area of protein glycosylation and is named as an inventor of several patents. Dr. Kumar received his BS in chemistry from Rohilkhand University, his MS in chemistry from Meerut University, his Ph.D. from University of New Brunswick and he completed his post-doctoral fellowship at Albert Einstein College of Medicine, in Bronx, NY.

Basic Compensation

Total Annual Compensation, USD 355,000
Restricted Stock Awards, USD 167,820
Long-Term Incentive Plans, USD --
All Other, USD 730,489
Fiscal Year Total, USD 1,253,310

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 66,162 1,373,970.00
Name Fiscal Year Total

Francois Nader


Habib Dable


Kevin McLaughlin


Matthew Sherman


Ravindra Kumar


John Quisel

As Of  30 Dec 2016